News: Guidelines by FDA for Clinical Trial Imaging
FDA recently published new guidelines for imaging endpoints in clinical trials. Invicro’s late-phase clinical operations team are experts in supporting clinical studies which depend upon imaging-based endpoints, in particular those in the oncology, CNS, musculoskeletal, and GI therapeutic areas. Read more >>
Contact Invicro for more information.